CSL

Every patient’s journey is unique, but one message comes through again and again: Trust yourself and keep asking questions.

Dee’s story is a powerful reminder that self-advocacy can play an important role in navigating a rare disease. At CSL, we’re committed to listening to patients and supporting the communities we serve. https://bit.ly/4rd4Riv

Our responsibility to patients goes beyond today.

Plasma-derived therapies are critical for people living with rare and serious diseases. At CSL, we’re working with others across the health care ecosystem to help safeguard the long-term availability of these important therapies and support sustainable access for the patients who rely on them.

It’s an opportunity to contribute to work that has an impact far beyond your role – and far beyond CSL.

Discover a career driven by purpose: https://csl.wd1.myworkdayjobs.com/en-EN/CSL_External

A rare diagnosis doesn’t define a person.

Every day, patients show remarkable resilience, determination and hope in the face of challenges most people never see. Their stories continue to inspire our purpose and our pursuit of innovation.

Behind every number is a person, a family and a story.

8.8 million patients worldwide received lifesaving plasma-derived and recombinant therapies through CSL in fiscal year 2025. It’s a reminder of what’s possible when science, innovation and compassion come together.

Why do engineers choose CSL?

For Harish, working as a Utilities Engineer means having opportunities to grow, learn and make an impact.

Hear directly from Harish about his experience and what makes engineering at CSL meaningful to him.

Ready to put your engineering skills to work with purpose? Explore opportunities with our team: https://csl.wd1.myworkdayjobs.com/en-EN/CSL_External

Today we're sharing our 2026 Annual Report.

We've taken important steps to strengthen CSL, improve performance and build a stronger foundation for sustainable growth. Along the way, we continued to serve patients around the world, advance innovation across our portfolio, invest in our manufacturing network and enhance the capabilities that will shape our future.

Most importantly, our people remained focused on what matters most: delivering life-saving and life-changing therapies, supporting public health, and making a meaningful difference for patients and donors worldwide.

As we look ahead, our focus is clear.

✅Drive portfolio innovation and growth
✅Lead the industry in operational excellence
✅Enable and elevate our people

Read our 2026 Annual Report: https://investors.csl.com/annualreport/2026/

What drives scientists to pursue breakthroughs in rare disease research?

For Giorgia, it starts with understanding the patient experience and how science can change it. Her work helps turn early research into real-world impacts for patients with rare kidney diseases – like delaying dialysis and improving quality of life.

Because timing can make all the difference for patients.

Explore how you can make an impact at CSL: https://csl.wd1.myworkdayjobs.com/en-EN/CSL_External?jobFamilyGroup=def6fe28d9a210a6c5f95ebef079cdfb

What does it take to help therapies safely reach patients around the world?

For Rishi Chopra, it starts with keeping patients at the center of every decision.

At CSL, he works across global Pharmacovigilance and Regulatory Affairs teams to help ensure therapies remain safe, effective and accessible for the people who need them most.

Because advancing science also means advancing responsibility.

Discover open R&D roles at CSL: https://csl.wd1.myworkdayjobs.com/en-EN/CSL_External?jobFamilyGroup=def6fe28d9a210a6c5f95ebef079cdfb

Living with a rare condition takes extraordinary courage.

At CSL, we’re continuously inspired by the determination, perseverance and hope shown by patients and families around the world. Their journeys motivate us to keep pushing science forward.